Cargando…
The atorvastatin metabolic phenotype shift is influenced by interaction of drug-transporter polymorphisms in Mexican population: results of a randomized trial
Atorvastatin (ATV) is a blood cholesterol-lowering drug used to prevent cardiovascular events, the leading cause of death worldwide. As pharmacokinetics, metabolism and response vary among individuals, we wanted to determine the most reliable metabolic ATV phenotypes and identify novel and preponder...
Autores principales: | León-Cachón, Rafael B. R., Bamford, Aileen-Diane, Meester, Irene, Barrera-Saldaña, Hugo Alberto, Gómez-Silva, Magdalena, Bustos, María F. García |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264171/ https://www.ncbi.nlm.nih.gov/pubmed/32483134 http://dx.doi.org/10.1038/s41598-020-65843-y |
Ejemplares similares
-
A pharmacogenetic pilot study reveals MTHFR, DRD3, and MDR1 polymorphisms as biomarker candidates for slow atorvastatin metabolizers
por: León-Cachón, Rafael B. R., et al.
Publicado: (2016) -
Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus
por: Sanchez-Ibarra, Hector E., et al.
Publicado: (2018) -
A novel method to detect the Mexican founder mutation BRCA1 ex9-12del associated with breast and ovarian cancer using quantitative polymerase chain reaction and TaqMan(®) probes
por: Martínez-Treviño, Denisse Aideé, et al.
Publicado: (2018) -
Association study of genetic polymorphisms in proteins involved in oseltamivir transport, metabolism, and interactions with adverse reactions in Mexican patients with acute respiratory diseases
por: Bermúdez de León, Mario, et al.
Publicado: (2020) -
Changes within the care of hematopoietic cell transplantation patients after the shift of a Mexican institution to a COVID-19-only center
por: Rivera-Franco, Monica M., et al.
Publicado: (2020)